Ganirelix
Description
Ganirelix is a competitive and selective gonadotropin releasing hormone (GnRH) antagonist. Ganirelix prevents endogenous GnRH from inducing luteinising hormone (LH) and follicle stimulating hormone release. Ganirelix counteracts Prostaglandin E2 (HY-101952)-induced detrusor overactivity, enhances Carbachol (HY-B1208)-induced detrusor contractions. Ganirelix can be used for the research of female infertility and detrusor overactivity.
Product Information
| Product Name | Ganirelix |
| Molecular Weight | 1570.32 |
| Formula | C80H113ClN18O13 |
| CAS Number | 124904-93-4 |
| Appearance | Solid |
| Color | White to off-white |
| Sequence | Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Tyr-D-{Har(Et,Et)}-Leu-{Har(Et,Et)}-Pro-D-Ala-NH2 |
| Sequence Shortening | Ac-{D-2Nal}-{D-Phe(4-Cl)}-{D-3Pal}-SY-{D-Har(Et,Et)}-L-{Har(Et,Et)}-P-{D-Ala}-NH2 |
| Storage | Sealed storage, away from moisture Powder -80??C 2 years -20??C 1 year *In solvent : -80??C, 6 months; -20??C, 1 month (sealed storage, away from moisture) |
